Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial

John Paul Diaz, Troy Gatcliffe, Zuanel Diaz, Eric Schroeder, Nicholas Lambrou, Nicole Eiseler, Thomas Morrissey

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGynecologic Oncology
Volume162
StatePublished - Aug 1 2021

Cite this